David Windley
Stock Analyst at Jefferies
(3.56)
# 1,561
Out of 4,976 analysts
191
Total ratings
65.98%
Success rate
13.37%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Initiates: Hold | $263 | $248.32 | +5.91% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $2.03 | +35.47% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $28.84 | +111.51% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $20.28 | -40.83% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $310.38 | -18.49% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $10.32 | +103.49% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $492.09 | -29.89% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $300.89 | +40.25% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $175.55 | +69.18% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $187.68 | +28.94% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $320.25 | +102.03% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.59 | +135.85% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $308.16 | +96.00% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $470.00 | -20.21% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.91 | -2.58% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $282.78 | -4.52% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $10.70 | +44.86% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $253.15 | +111.73% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $25.53 | +13.59% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $162.00 | +25.31% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $177.81 | +69.84% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.84 | +3,063.27% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.55 | - | 5 | Oct 9, 2017 |
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $248.32
Upside: +5.91%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $2.03
Upside: +35.47%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $28.84
Upside: +111.51%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $20.28
Upside: -40.83%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $310.38
Upside: -18.49%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $10.32
Upside: +103.49%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $492.09
Upside: -29.89%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $300.89
Upside: +40.25%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $175.55
Upside: +69.18%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $187.68
Upside: +28.94%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $320.25
Upside: +102.03%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.59
Upside: +135.85%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $308.16
Upside: +96.00%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $470.00
Upside: -20.21%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.91
Upside: -2.58%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $282.78
Upside: -4.52%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $10.70
Upside: +44.86%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $253.15
Upside: +111.73%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $25.53
Upside: +13.59%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $162.00
Upside: +25.31%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $177.81
Upside: +69.84%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.84
Upside: +3,063.27%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.55
Upside: -